National Institute on Drug Abuse; Notice of Closed Meeting, 73866 [2013-29288]

Download as PDF maindgalligan on DSK5TPTVN1PROD with NOTICES 73866 Federal Register / Vol. 78, No. 236 / Monday, December 9, 2013 / Notices In-Person Public Participation and Building Access: For in-person participants, the meetings will be held in the National Institutes of Health (NIH) Porter Building (Building 35) as noted above in the Addresses section. Details regarding registration capacity and directions will be posted on www.DietaryGuidelines.gov. For inperson participants, check-in at the registration desk on-site at the meeting is required and will begin at 7:15 a.m. each day. Oral Testimony: For the meeting originally scheduled for October 3–4, 2013, the Committee invited requests from the public to present three minutes of oral testimony. Individuals who were confirmed to speak or who were on standby will retain their designation and order for this rescheduled meeting. Further instructions for participation on January 14, 2014 (day 2) will be sent to those individuals. Written Public Comments: Written comments from the public will continue to be accepted throughout the Committee’s deliberative process. Written public comments can be submitted and/or viewed at www.DietaryGuidelines.gov using the ‘‘Submit Comments’’ and ‘‘Read Comments’’ links, respectively. Written comments received by December 31, 2013 will ensure transmission to the Committee prior to this meeting. As the Committee continues its work, it may request public comments on specific topics; these requests and any instructions for submitting requested comments will be posted on the Web site. Meeting Documents: Documents pertaining to Committee deliberations, including meeting agendas, summaries, and transcripts will be available on www.DietaryGuidelines.gov under ‘‘Meetings,’’ and meeting materials will be available for public viewing at the meeting. Meeting information, thereafter, will continue to be accessible online, at the NIH Library, and upon request at the Office of Disease Prevention and Health Promotion, OASH/HHS; 1101 Wootton Parkway, Suite LL100 Tower Building; Rockville, MD 20852: Telephone (240) 453–8280; Fax: (240) 453–8281. Dated: December 3, 2013. Don Wright, Deputy Assistant Secretary for Health, Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services. Dated: December 3, 2013. Jackie Haven, Acting Executive Director, Center for Nutrition Policy and Promotion, U.S. Department of Agriculture. Dated: December 3, 2013. Chavonda Jacobs-Young, Acting Administrator, Agricultural Research Service, U.S. Department of Agriculture. [FR Doc. 2013–29291 Filed 12–6–13; 8:45 am] 17:03 Dec 06, 2013 Jkt 232001 Dated: December 4, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–29285 Filed 12–6–13; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Advisory Board, December 09, 2013, 04:00 p.m. to December 10, 2013, 05:00 p.m., National Institutes of Health, Building 31, 31 Center Drive, Bethesda, MD, 20892 which was published in the Federal Register on November 25, 2013, 78 FR 70312. The meeting notice is amended to change the time of the Subcommittee meeting on Planning & Budget on December 9, 2013 from 7:45 p.m. to 9:15 p.m. The Subcommittee meeting was originally scheduled to be held from 4:00 p.m. to 5:30 p.m. The Subcommittee meeting is open to the public. This notice is being published less than 15 days prior to the meeting due to scheduling constraints. Dated: December 3, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–29286 Filed 12–6–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel, December 18, 2013, 10:00 a.m. to December 18, 2013, 06:00 VerDate Mar<15>2010 p.m., National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 which was published in the Federal Register on November 29, 2013, 78 FR 71628. The meeting notice is amended to change the date of the meeting from December 18, 2013 to December 17, 2013. The meeting is closed to the public. PO 00000 Frm 00051 Fmt 4703 Sfmt 9990 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Center for Genetics Studies (7789). Date: January 7, 2014. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Lyle Furr, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892– 9550, (301) 435–1439, lf33c.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: December 3, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–29288 Filed 12–6–13; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\09DEN1.SGM 09DEN1

Agencies

[Federal Register Volume 78, Number 236 (Monday, December 9, 2013)]
[Notices]
[Page 73866]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29288]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; NIDA Center for Genetics Studies (7789).
    Date: January 7, 2014.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 435-1439, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: December 3, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-29288 Filed 12-6-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.